Evaluation of Strawberry Host Plant Resistance to Powdery Mildew in 38 Genotypes Under Greenhouse Conditions in San Luis Obispo, California, Winter 2026
Plant Health Progress · 31.10.2026
DOI: 10.1094/php-08-26-0161-pdmr ↗Kurz gefasst
Fachartikel in der Zeitschrift Plant Health Progress, online erschienen am 31.10.2026. Verfasst von Marina J. Gutierrez und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Podosphaera aphanis , the causal agent of strawberry powdery mildew, is an economically important disease that infects all above-ground plant parts. Signs of the pathogen appear as white powdery patches of mycelia, on both sides of leaves. This report evaluates the host resistance to powdery mildew of 38 cultivars and elite breeding lines (genotypes) under greenhouse conditions in San Luis Obispo, California, in winter of 2026. Weekly assessments of disease incidence and severity were evaluated. The results of this study will provide strawberry growers with information to make informed decisions on selecting resistant cultivars for effective powdery mildew management.
Zitieren
APA
Gutierrez, M. J., Spencer, S. A., Blauer, K. A., & Holmes, G. J. (2026). Evaluation of Strawberry Host Plant Resistance to Powdery Mildew in 38 Genotypes Under Greenhouse Conditions in San Luis Obispo, California, Winter 2026. Plant Health Progress. https://doi.org/10.1094/php-08-26-0161-pdmr
Vancouver
Gutierrez MJ, Spencer SA, Blauer KA, Holmes GJ. Evaluation of Strawberry Host Plant Resistance to Powdery Mildew in 38 Genotypes Under Greenhouse Conditions in San Luis Obispo, California, Winter 2026. Plant Health Progress. 2026. doi:10.1094/php-08-26-0161-pdmr
BibTeX
@article{Gutierrez2026,
author = {Gutierrez, Marina J. and Spencer, Shaelyn A. and Blauer, Kyle A. and Holmes, Gerald J.},
title = {Evaluation of Strawberry Host Plant Resistance to Powdery Mildew in 38 Genotypes Under Greenhouse Conditions in San Luis Obispo, California, Winter 2026},
journal = {Plant Health Progress},
year = {2026},
doi = {10.1094/php-08-26-0161-pdmr}
}
EUVIMED